Skip to content
GLP-1 Savers
Menu
Ranked #8 · Good ValueEditorial review

Hims & Hers review

A familiar, app-first brand with an up-front $199 semaglutide price and nationwide reach.

Est. first month

$199/mo

Save ~85% vs brand-name
Get this deal Editorial review — no commercial relationship.
No teaser step-up. Semaglutide priced up front; tirzepatide pricing isn't consistently shown.
Semaglutide
$199/mo
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

The Value Score card

Hims & Hers scored on our six published factors. See the methodology.

Lowest Real Price78/100
No Teaser-Rate Bait78/100
Nationwide Availability98/100
Both Molecules70/100
Easy Cancellation82/100
Reputation86/100

Why it's a deal

  • Up-front $199 semaglutide
  • Available in all 50 states
  • Slick app experience and strong brand trust

Read the fine print

  • Tirzepatide pricing not consistently disclosed
  • Compounded supply has drawn industry-wide regulatory scrutiny
  • Editorial pick — no affiliate relationship

The bottom line

Best for: People who want a familiar consumer brand and a visible semaglutide price. A familiar, app-first brand with an up-front $199 semaglutide price and nationwide reach.

Ranked #8 of 9 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

All 8 other programs we track, by Value Score.

Pricing, states and verification reflect Hims & Hers's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Hims & Hers's site. Not medical advice; see our disclosure.

← Back to all deals